Table 2.
Serum levels of NGF, BDNF, VEGF and PGE2 biomarkers in study groups
Biomarker | Episodic migraine (n=23) | Chronic migraine (n=36) | Controls (n=30) | P-value¶ |
---|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | ||
NGF | 63.11 (24.56) *, # | 75.88 (31.89) * | 90.58 (70.25) # | 0.009 |
BDNF | 0.49 (0.13) * | 0.49 (0.14) # | 1.05 (0.96) *, # | <0.001 |
VEGF | 937.41 (230.23) | 932.56 (301.35) | 646.50 (292.50) | 0.046 |
PGE2 | 120.71 (19.47)* | 134.16 (38.57) | 153.50 (55.69)* | 0.001 |
¶: Across group comparison (Kruskal-Wallis); *, #: significant adjusted P-value for pairwise-comparison (Dunn-Bonferroni); NGF: nerve growth factor; BDNF: brain-derived neurotrophic factor; VEGF: vascular endothelial growth factor; PGE2: prostaglandin E2